SCHEMBL23006359

SCHEMBL23006359

CC(C)(C)OC(=O)N1C[C@@H](CCC(C)(N)c2ccccn2)CC1(C)C

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.39
CYP19A1 P11511 1/20 0.35
USP30 Q70CQ3 1/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
ADORA2A P29274 2/20 0.33
ADORA2B P29275 2/20 0.33
GRM5 P41594 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
KDM1A O60341 1/20 0.33
NAMPT P43490 1/20 0.33
BACE1 P56817 2/20 0.33
JAK1 P23458 1/20 0.33
CTSD P07339 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29862409 1.00 GPR119 (0.39) GPR119CYP19A1USP30CNR1CNR2
SCHEMBL22982348 0.88 CHRM3 (0.36) CYP19A1CNR1CNR2KDM4E
SCHEMBL23006351 0.84 GPR119 (0.37) GPR119CYP19A1USP30CNR1CNR2
SCHEMBL23006350 0.82 GPR119 (0.35) GPR119CYP19A1USP30CNR1CNR2
SCHEMBL29862313 0.81 GPR119 (0.40) GPR119USP30ADORA2AADORA2BGRM5
SCHEMBL23006911 0.81 GPR119 (0.40) GPR119USP30ADORA2AADORA2BGRM5
SCHEMBL23005931 0.81 GPR119 (0.40) GPR119USP30ADORA2AADORA2BGRM5
SCHEMBL23006358 0.81 SMN1; SMN2 (0.41) GPR119USP30KDM4E
SCHEMBL23006360 0.80 GPR119 (0.41) GPR119USP30ADORA2AADORA2BGRM5
SCHEMBL23006678 0.80 TGFBR1 (0.33) GPR119CYP19A1USP30CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114585628-B Modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2024-03-26 CN disclosed
CN-114585628-A Modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2022-06-03 CN disclosed
WO-2021030556-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-02-18 WO disclosed